Significance of eosinophilia after stem cell transplantation as a possible prognostic marker for favorable outcome

[1]  R. Seshadri,et al.  EOSINOPHILIA CORRELATES WITH THE PRESENCE OR DEVELOPMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN CHILDREN , 2004, Transplantation.

[2]  C. Abramowsky,et al.  Peripheral eosinophilia and eosinophilic gastroenteritis after pediatric liver transplantation , 2003, Pediatric transplantation.

[3]  M. Battaglia,et al.  The role of interleukin 10 in the control of autoimmunity. , 2003, Journal of autoimmunity.

[4]  F. Brito-Babapulle.  The eosinophilias, including the idiopathic hypereosinophilic syndrome , 2003, British journal of haematology.

[5]  M. Sabel,et al.  Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. , 2002, Cancer research.

[6]  N. Brousse,et al.  Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation , 2002, Transplantation.

[7]  M. Kiehl,et al.  Eosinophilia indicates the evolution to acute graft-versus-host disease. , 2002, Blood.

[8]  A. Janin,et al.  Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease. , 2002, Blood.

[9]  S. Ye,et al.  Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma , 2001, Cancer Gene Therapy.

[10]  G. Gardani,et al.  Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients. , 2001, Journal of biological regulators and homeostatic agents.

[11]  J. V. Stone,et al.  Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. , 2001, Blood.

[12]  Y. Oomoto,et al.  Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease. , 2000, International journal of hematology.

[13]  G. Szot,et al.  Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. , 1997, Blood.

[14]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[15]  B. Bolwell,et al.  Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen. , 1994, Bone marrow transplantation.

[16]  James,et al.  Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. , 1989, Blood.

[17]  A. Rimm,et al.  Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. , 1989, Bone marrow transplantation.

[18]  F. Appelbaum,et al.  Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up , 1988 .

[19]  A. Gratwohl,et al.  European experience of bone marrow transplantation for leukemia. , 1987, Transplantation proceedings.

[20]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.